In vitro antimicrobial susceptibility of Mycoplasma bovis isolated in Israel from local and imported cattle

Veterinary Microbiology

Volumn 137, Issue 3-4, 2009, Pages 268-275

  Gerchman, Irena ^a   Levisohn, Sharon ^a   Mikula, Inna ^a   Lysnyansky, Inna ^a  

^a KIMRON VETERINARY INSTITUTE   (Israel)

Author keywords

Aminoglycoside; Fluoroquinolones; Macrolides; Minimal inhibitory concentration; Mycoplasma bovis; Tetracyclines

Indexed keywords

AMINOGLYCOSIDE; DANOFLOXACIN; DOXYCYCLINE; ENROFLOXACIN; GENTAMICIN; MACROLIDE; MARBOFLOXACIN; OXYTETRACYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; STREPTOMYCIN; TETRACYCLINE; TILMICOSIN; TYLOSIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CATTLE; IN VITRO STUDY; ISRAEL; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA BOVIS; NONHUMAN;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CATTLE DISEASES; COMMERCE; DRUG RESISTANCE, BACTERIAL; ISRAEL; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA BOVIS; MYCOPLASMA INFECTIONS; TETRACYCLINES;

ANIMALIA; BOS; BOVINAE; MYCOPLASMA BOVIS; MYCOPLASMATALES;

EID: 67349158760     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.01.028     Document Type: Article

References (31)

1. Adegboye D.S., Halbur P.G., Cavanaugh D.L., Werdin R.E., Chase C.C.L., Miskimins D.W., and Rosenbusch R.F. Immunohistochemical and pathological study of Mycoplasma bovis associated lung abcesses in calves. J. Vet. Diagn. Invest. 7 (1995) 333-337
2. Arcangioli M.A., Duet A., Meyer G., Dernburg A., Bezille P., Poumarat F., and Le Grand D. The role of Mycoplasma bovis in bovine respiratory disease outbreaks in veal calf feedlots. Vet. J. 177 (2008) 89-93
3. Ayling R.D., Baker S.E., Peek M.L., Simon A.J., and Nicholas R.A. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against recent field isolates of Mycoplasma bovis. Vet. Rec. 146 (2000) 745-747
4. Ayling R.D., Bashiruddin S.E., and Nicholas R.A. Mycoplasma species and related organisms isolated from ruminants in Britain between 1990 and 2000. Vet. Rec. 155 (2004) 413-416
5. Bebear C., and Robertson J.A. Determination of minimal inhibitory concentration. In: Razin S., and Tully J.G. (Eds). Molecular and Diagnostic Procedures in Mycoplasmology (1995), Academic Press, Orlando, FA 189-197
6. Blackburn P., Brooks C., McConnell W., and Ball H.J. Isolation of Mycoplasma bovis from cattle in Northern Ireland from 1999 to 2005. Vet. Rec. 161 (2007) 452-453
7. Brice N., Finlay D., Bryson D.G., Henderson J., McConnell W., and Ball H.J. Isolation of Mycoplasma bovis from cattle in Northern Ireland, 1993 to 1998. Vet. Rec. 146 (2000) 643-644
8. Byrne W.J., McCormack R., Brice N., Egan J., Markey B., and Ball H.J. Isolation of Mycoplasma bovis from bovine clinical samples in the Republic of Ireland. Vet. Rec. 148 (2001) 331-333
9. Francoz D., Fortin M., Fecteau G., and Messier S. Determination of Mycoplasma bovis susceptibilities against six antimicrobial agents using the E test method. Vet. Microbiol. 105 (2005) 57-64
10. Gagea M.I., Bateman K.G., van Dreumel T., McEwen B.J., Carman S., Archambault M., Shanahan R.A., and Caswell J.L. Diseases and pathogens associated with mortality in Ontario beef feedlots. J. Vet. Diagn. Invest. 18 (2006) 18-28
11. Gerchman I., Lysnyansky I., Perk S., and Levisohn S. In vitro susceptibilities to fluoroquinolones in current and archived Mycoplasma gallisepticum and Mycoplasma synoviae isolates from meat-type turkeys. Vet. Microbiol. 131 (2008) 266-276
12. Haines D.M., Martin K.M., Clark E.G., Jim G.K., and Janzen E.D. The immunohistochemical detection of Mycoplasma bovis and bovine viral diarrhea virus in tissues of feedlot cattle with chronic, unresponsive respiratory disease and/or arthritis. Can. Vet. J. 42 (2001) 857-860
13. Hannan P.C. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. Vet. Res. 31 (2000) 373-395
14. Hannan P.C.T., O'Hanolon P.J., and Rogers N.H. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Res. Vet. Sci. 46 (1989) 202-211
15. Hannan P.C.T., Windsor G.D., de Jong A., Schmeer N., and Stegemann H. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrob. Agents Chemother. 41 (1997) 2037-2040
16. Hirose K., Kobayashi H., Ito N., Kawasaki Y., Zako M., Kotani K., Ogawa H., and Sato H. Isolation of mycoplasmas from nasal swabs of calves affected with respiratory diseases and antimicrobial susceptibility of their isolates. J. Vet. Med. B 50 (2003) 347-351
17. Jordan F.T.W., and Horrocks B.K. The minimum inhibitory concentration of tilmicosin and tylosin for Mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks. Avian Dis. 40 (1996) 326-334
18. Kays M.B., and Graff M.A. Broth microdilution and E-test for determining fluoroquinolone activity against Streptococcus pneumoniae. Ann. Pharmacother. 36 (2002) 416-422
19. Le Grand D., Calavas D., Brank M., Citti C., Rosengarten R., Bezille P., and Poumarat F. Serological prevalence of Mycoplasma bovis infection in suckling beef cattle in France. Vet. Rec. 150 (2002) 268-273
20. Meynell G.G., and Meynell E. Theory and Practice in Experimental Bacteriology. 2nd edition (1970), Cambridge University Press, Cambridge, UK
21. NCCLS, 2002. Development of in vitro susceptability testing criteria and quality control parameters for veterinary antimicrobial agents; Approved guideline, 22.
22. Rodwell A.W., and Whitcomb R.F. Methods for direct and indirect measurement of mycoplasma growth. In: Razin S., and Tully J.G. (Eds). Methods in Mycoplasmology (1983), Academic Press, New York 185-196
23. Rosenbusch R.F., Kinyon J.M., Apley M., Funk N.D., Smith S.C., and Hoffman L.J. In vitro antimicrobial inhibition profiles of Mycoplasma bovis isolates recovered from various regions of the United States from 2002 to 2003. J. Vet. Diagn. Invest. 17 (2005) 436-441
24. Rosengarten R., Behrens A., Stetefeld A., Heller M., Ahrens M., Sachse K., Yogev D., and Kirchhoff H. Antigen heterogeneity among isolates of Mycoplasma bovis is generated by high-frequency variation of diverse membrane surface proteins. Infect. Immun. 62 (1994) 5066-5074
25. Rosengarten R., and Yogev D. Variant colony surface antigenic phenotypes within mycoplasma strain populations: implications for species diagnosis and strain standardization. J. Clin. Microbiol. 34 (1996) 149-158
26. Shahriar F.M., Clark E.G., Janzen E., West K., and Wobeser G. Coinfection with bovine viral diarrhea virus and Mycoplasma bovis in feedlot cattle with chronic pneumonia. Can. Vet. J. 43 (2002) 863-868
27. ter Laak E.A., Noordergraaf J.H., and Verschure M.H. Susceptibilities of Mycoplasma bovis, Mycoplasma dispar, and Ureaplasma diversum strains to antimicrobial agents in vitro. Antimicrob. Agents Chemother. 37 (1993) 317-321
28. Thomas A., Ball H., Dizier I., Trolin A., Bell C., Mainil J., and Linden A. Isolation of mycoplasma species from the lower respiratory tract of healthy cattle and cattle with respiratory disease in Belgium. Vet. Rec. 151 (2002) 472-476
29. Thomas A., Nicolas C., Dizier I., Mainil J., and Linden A. Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium. Vet. Rec. 153 (2003) 428-431
30. Vester B., and Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45 (2001) 1-12
31. Wu C.M., Wu H., Ning Y., Wang J., Du X., and Shen J. Induction of macrolide resistance in Mycoplasma gallisepticum in vitro and its resistance-related mutations within domain V of 23S rRNA. FEMS Microbiol. Lett. 247 (2005) 199-205